Potential New Option in Aggressive, Ultra Rare Sarcoma

(MedPage Today) -- Treatment with an investigational albumin-bound mTOR inhibitor showed long-lasting responses in patients with advanced malignant perivascular epithelioid cell tumors (PEComa), extended follow-up from the single-arm AMPECT study...